← FDA Drug Approvals (Drugs@FDA)

TRI-LO-ESTARYLLA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2015-06-29

Drug application

FDA Application #

ANDA091232

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRI-LO-ESTARYLLA

Generic name

NORGESTIMATE AND ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORGESTIMATE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

AvKARE

First approval

2015-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown